These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 2022941

  • 21. Modeling the influence of chronopharmacological administration of synthetic glucocorticoids on the hypothalamic-pituitary-adrenal axis.
    Rao RT, Scherholz ML, Androulakis IP.
    Chronobiol Int; 2018 Nov; 35(12):1619-1636. PubMed ID: 30059634
    [Abstract] [Full Text] [Related]

  • 22. Suppression and recovery of the hypothalamic function after high-dose corticosteroid treatment in preterm infants.
    Ng PC, Lam CW, Lee CH, Chan IH, Wong SP, Fok TF.
    Neonatology; 2008 Nov; 94(3):170-5. PubMed ID: 18612214
    [Abstract] [Full Text] [Related]

  • 23. Cortisol secretary pattern and glucocorticoid feedback sensitivity in women from a Mediterranean area: relationship with anthropometric characteristics, dietary intake and plasma fatty acid profile.
    García-Prieto MD, Tébar FJ, Nicolás F, Larqué E, Zamora S, Garaulet M.
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):185-91. PubMed ID: 17223986
    [Abstract] [Full Text] [Related]

  • 24. The low-dose (1 microg) adrenocorticotropin stimulation test in kidney and kidney-pancreas transplant patients: a potential guideline for steroid withdrawal.
    Baz-Hecht M, Osher E, Yachnin T, Nakache R, Nakache G, Tordjman K, Stern N.
    Clin Transplant; 2006 Feb; 20(1):72-7. PubMed ID: 16556157
    [Abstract] [Full Text] [Related]

  • 25. An open-label adrenal suppression study of 0.1% fluocinonide cream in pediatric patients with atopic dermatitis.
    Schlessinger J, Miller B, Gilbert RD, Plott RT, Vanos Study Group.
    Arch Dermatol; 2006 Dec; 142(12):1568-72. PubMed ID: 17178982
    [Abstract] [Full Text] [Related]

  • 26. Sensitivity of the hypothalamic-pituitary-adrenal system of pigeons (Columba livia domestica) to suppression by dexamethasone, cortisol, and prednisolone.
    Westerhof I, Van den Brom WE, Mol JA, Lumeij JT, Rijnberk A.
    Avian Dis; 1994 Dec; 38(3):435-45. PubMed ID: 7832695
    [Abstract] [Full Text] [Related]

  • 27. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
    Ringdal N, Lundbäck B, Alton M, Rak S, Eivindson A, Bratten G, Kjaersgaard P.
    Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
    [Abstract] [Full Text] [Related]

  • 28. Time to recovery of the hypothalamic-pituitary-adrenal axis after curative resection of adrenal tumors in patients with Cushing's syndrome.
    Doherty GM, Nieman LK, Cutler GB, Chrousos GP, Norton JA.
    Surgery; 1990 Dec; 108(6):1085-90. PubMed ID: 2247834
    [Abstract] [Full Text] [Related]

  • 29. The role of corticosterone in human hypothalamic-pituitary-adrenal axis feedback.
    Raubenheimer PJ, Young EA, Andrew R, Seckl JR.
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):22-6. PubMed ID: 16817814
    [Abstract] [Full Text] [Related]

  • 30. Corticosteroids in asthma.
    Dunlap NE, Bailey WC.
    South Med J; 1990 Apr; 83(4):428-32. PubMed ID: 2181691
    [Abstract] [Full Text] [Related]

  • 31. Adrenal insufficiency after glucocorticoid withdrawal in children with rheumatic diseases.
    Huber BM, Bolt IB, Sauvain MJ, Flück CE.
    Acta Paediatr; 2010 Dec; 99(12):1889-93. PubMed ID: 20649769
    [Abstract] [Full Text] [Related]

  • 32. [How to plan glucocorticoid withdrawal: diagnostic and therapeutic strategies].
    Vollenweider P, Waeber G.
    Praxis (Bern 1994); 2003 Oct 01; 92(40):1675-82. PubMed ID: 14579472
    [Abstract] [Full Text] [Related]

  • 33. [Treatment of iatrogenic Cushing syndrome: questions of glucocorticoid withdrawal].
    Igaz P, Rácz K, Tóth M, Gláz E, Tulassay Z.
    Orv Hetil; 2007 Feb 04; 148(5):195-202. PubMed ID: 17344139
    [Abstract] [Full Text] [Related]

  • 34. Clinical review: corticotherapy in sepsis.
    Prigent H, Maxime V, Annane D.
    Crit Care; 2004 Apr 04; 8(2):122-9. PubMed ID: 15025773
    [Abstract] [Full Text] [Related]

  • 35. Perioperative management of patients treated with glucocorticoids.
    Axelrod L.
    Endocrinol Metab Clin North Am; 2003 Jun 04; 32(2):367-83. PubMed ID: 12800537
    [Abstract] [Full Text] [Related]

  • 36. Corticosteroids: clinical pharmacology and therapeutic use.
    Swartz SL, Dluhy RG.
    Drugs; 1978 Sep 04; 16(3):238-55. PubMed ID: 209958
    [Abstract] [Full Text] [Related]

  • 37. Effects of intrauterine exposure to synthetic glucocorticoids on fetal, newborn, and infant hypothalamic-pituitary-adrenal axis function in humans: a systematic review.
    Tegethoff M, Pryce C, Meinlschmidt G.
    Endocr Rev; 2009 Dec 04; 30(7):753-89. PubMed ID: 19837868
    [Abstract] [Full Text] [Related]

  • 38. Hypothalamic-pituitary-adrenal axis suppression related to topical glucocorticoid therapy in a child with psoriatic exfoliative erythroderma.
    Campbell LS, Chevalier M, Levy RA, Rhodes A.
    Pediatr Dermatol; 2012 Dec 04; 29(1):101-4. PubMed ID: 21995486
    [Abstract] [Full Text] [Related]

  • 39. Steroids and the surgical patient.
    Jabbour SA.
    Med Clin North Am; 2001 Sep 04; 85(5):1311-7. PubMed ID: 11565501
    [Abstract] [Full Text] [Related]

  • 40. Hypothalamic-pituitary-adrenal axis recovery after treatment of Cushing's syndrome.
    Balasko A, Zibar Tomsic K, Kastelan D, Dusek T.
    J Neuroendocrinol; 2022 Aug 04; 34(8):e13172. PubMed ID: 35726348
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.